Northrop Grumman does not expect an ongoing antitrust review of its acquisition of Orbital ATK to have any “adverse impact” on the company, said CEO Kathy Warden.
Northrop Grumman does not expect an ongoing antitrust review of its acquisition of Orbital ATK to have any “adverse impact” on the company, said CEO Kathy Warden.